Business
Website Update
Website Update.
About this update from Sareum Holdings Plc
[{"type":"text","content":"\n \nRNS Number : 0826H Sareum Holdings PLC 23 May 2011 \n\n\n\n\n\n(AIM: SAR)\n\n\n23 May 2011\n\n\n\n\nSAREUM HOLDINGS PLC(\"Sareum\" or the \"Company\") \nSareum Website Update\nSareum (AIM: SAR), the specialist cancer drug discovery business, is pleased to announce that the following documents are now available for download at the Company's website, www.sareum.co.uk:\n· Sareum Research Note dated 23 May 2011, prepared by the Company's broker, Hybridan LLP\n· Presentation given by Dr John Reader at the One Nucleus Oncology Leadership Meeting, 12 May 2011 \n\n\n\n\nSareum Holdings plc\n\n\n\n\n\n\n\nTim Mitchell\n\n\n01223 497 700\n\n\n\n\n\n\n\n\n\n\n\n\nMerchant Securities Limited (Nomad)\n\n\n\n\nSimon Clements\n\n\n020 7628 2200\n\n\n\n\n\n\n\n\n\n\n\n\nHybridan LLP (Broker)\n\n\n\n\n\n\n\nClaire Noyce\n\n\n020 7947 4350\n\n\n\n\nNotes for editors: \nAbout Sareum Holdings plc\nSareum is a drug discovery company, headquartered in Cambridge UK, that is focused on producing targeted small molecule therapeutics to address unmet medical needs, primarily in cancer. Sareum aims to successfully deliver drug candidates for licensing to pharmaceutical and biotechnology companies at the pre-clinical or early clinical trials stage.\nSareum's Chk1 kinase cancer research programme is a joint research collaboration with The Institute of Cancer Research and Cancer Research Technology Limited. Novel chemical compounds developed by the collaboration have been shown to increase the effectiveness of current cancer therapeutics in in-vivo cancer models.\nSKIL® (Sareum Kinase Inhibitor Library) is Sareum's drug discovery technology platform that has so far produced the Company's Aurora, VEGFR-3, ALK, FLT3 & TYK2 kinase cancer and auto-immune disease research programmes. SKIL can also generate drug research programmes against other kinase targets.\nSareum Holdings plc joined the AIM market of the London Stock Exchange in October 2004, trading under the symbol SAR. For further information, please visit www.sareum.co.uk\n \n\nThis information is provided by RNSThe company news service from the London Stock Exchange END NRASEUSUDFFSEEI\n ","length":5213,"tagName":"div"}]